Popular Japanese Goku “Sleeping Time Machine” Spa Opens First Location In The US
Popular Japanese Goku “Sleeping Time Machine” Spa Opens First Location In The US Head massage specialist salon Goku no Kimochi may be the most sought-after massage establishment in Japan. Since they opened their first shop in Kyoto in 2008, their waiting list across all branches now exceeds 436,000 people. This popular spa officially opened in … Continue reading Popular Japanese Goku “Sleeping Time Machine” Spa Opens First Location In The US
Affinity Living Group launches daily exercise campaign utilizing National Institute on Aging resources
Affinity Living Group launches daily exercise campaign utilizing National Institute on Aging resources Hickory, NC, June 5, 2019 – Affinity Living Group (ALG) has launched a physical activity and exercise program across its more than 120 communities this month, using the science-based information from Go4Life®, an outreach initiative developed by the National Institute on Aging, part of the … Continue reading Affinity Living Group launches daily exercise campaign utilizing National Institute on Aging resources
The Cornucopia Institute Examines Plant-Based Beverages
The Cornucopia Institute Examines Plant-Based Beverages Advertising Promotes Them as a Health Food—But Are They? https://www.cornucopia.org/2019/06/plant-based-beverage-report-release/Cornucopia, WI — Cornucopia’s new report, “Pouring” Over Plant-Based Beverages, takes an in-depth look at what these beverages really offer consumers, how they are marketed, and how they compare to cow’s milk. Amid health concerns and dire climate crisis predictions, more consumers … Continue reading The Cornucopia Institute Examines Plant-Based Beverages
Rapid Dose Therapeutics Appoints Vice President, Research & Innovation
Rapid Dose Therapeutics Appoints Vice President, Research & Innovation BURLINGTON, ON, June 6, 2019 /CNW/ – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished scientist and management … Continue reading Rapid Dose Therapeutics Appoints Vice President, Research & Innovation
VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia
AbbVie Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia pERC conditionally recommends reimbursement of VENCLEXTA® (venetoclax) in combination with rituximab for the treatment of adult patients with chronic lymphocytic leukemia (CLL) who have received at least one … Continue reading VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia
